A thromboelastography study on the in vitro effects of L-arginine and L-N(G)-nitro arginine methyl ester on human whole blood coagulation and fibrinolysis

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 7, 1996, Pages 678-683

  Dambisya, Y M ^a   Lee, T L ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Coagulation cascade; Native whole blood; Nitric oxide; Nitric oxide synthase inhibitors; Platelet aggregation; Thromboelastography

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY;

EID: 0029804897     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199610000-00003     Document Type: Article

References (43)

1. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
2. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
3. Radomski MW, Palmer RMJ, Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325-328.
4. Hibbs JB Jr, Tainton RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Comm 1988; 157: 87-94.
5. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 1989; 261: 293-296.
6. Wood PL, Emmett MR, Rao TS, Cler J, Mick S, Iyengar S. Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quis-qualate-, kianate-, harma-line- and pentylenetetrazol-dependent increases in cerebellar cyclic GMP in vivo. J Neurochem 1990; 55: 346-348.
7. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38: 1709-1718.
8. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
9. Moncada S, Radomski MW, Palmer RMJ. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-2501.
10. Busee R, Luckhoff A, Bassenge E. Endothelium-derived relaxing factor inhibits platelet action. Naunyn-Schmeideberg's Arch Pharmacol 1987; 336: 566-571.
11. Radomski MW, Palmer RMJ, Moncada S. An L-arginine:nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197.
12. Bohme E, Jung R, Melcher I. Guanylate cyclase in human platelets. Meth Enzymol 1974; 38: 199-202.
13. Haslam RJ, Davidson MM, Davies T, Lynham JA, McClenaghan MD. Regulation of blood platelet function by cyclic nucleotides. Adv Cyclic Nucleotide Res 1978; 9: 533-552.
14. Steer ME, Salzman EW. Cyclic nucleotide in hemostasis and thrombosis. Adv Cyclic Nucleotide Res 1980; 12: 71-92.
15. Mellion BT, Ignarro EJ, Ohlstein EH, Pontecorro EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosme 3′,5′-monophosphate and ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-955.
16. Duarte IDG, Lorenzetti BB, Ferreira SH. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990; 186: 289-293.
17. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198-202.
18. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
19. Wang P, Ba ZF, Chaudry IH. Nitric oxide: to block or enhance its production during sepsis? Arch Surg 1994; 129: 1137-1143.
20. Rodeberg DA, Cheat MS, Bass RC, Arkovitz MS, Garcia VF. Nitric oxide: an overview. Am J Surg 1995; 170: 292-303.
21. Tuman KJ, McCarthy RJ, Ivankovich AD. The thromboelastograph: is it the solution to coagulation problems? Cardiothorac Vasc Anesth Update 1991; 2: 1-13.
22. Mallet SV, Cox JA. Thromboelastography. Br J Anaesth 1992; 69: 307-313.
23. Dambisya YM, Lee T-L, Gopalakrishnakone P. Action of Calloselasma rhodostoma (Malayan pit viper) venom on human blood coagulation and fibrinolysis using computerized thromboelastography (CTEG). Toxicon 1994; 32: 1619-1626.
24. Dambisya YM, Lee T-L, Gopalakrishnakone P. Anticoagulant effects of Pseudechis australis (Australian king brown snake) venom on human blood: a computerized thromboelastography study. Toxicon 1995: 33: 1378-1382.
25. Dambisya YM, Lee T-L, Hussaini IM. Effects of the platelet-activating factor receptor antagonist WEB 2086 on whole blood coagulation and fibrinolysis in a thromboelastography assay. Blood Coag Fibrinol 1995; 6: 733-737.
26. G-monomethyl arginine (L-NMMA) and L-arginine on the antinociceptive effects of morphine in the mouse. Meth Find Exp Clin Pharmacol 1995; 17: 577-582.
27. Dambisya YM, Lee T-L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 1996; 117: 914-918.
28. Gianott L, Alexander JW, Pyles T, Fukushiwa R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance: the role of nitric oxide. Ann Surg 1993; 217: 644-654.
29. Petros A, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
30. Dambisya YM, Lee T-L. Effects of L-arginine and L-NAME on whole blood coagulation and fibrinolysis in a thromboelastography (TEG) assay. Abstracts, 7th Southeast Asian/Western Pacific Regional Meeting of Pharmacologists, 21-25 November, Manila, Philippines, 1995; 60.
31. Kang YG, Lewis J, Navalgund A, et al. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987; 66: 766-773.
32. Kang YG, Borland LM, Picone J, Martin LK. Intraoperative coagulation changes in children undergoing liver transplantation. Anesthesiology 1989; 71: 44-47.
33. Radomski MW, Palmer RMJ, Moncada S. The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-649.
34. Matsumoto M, Kishikawa H, Mon A. Guanido compounds in the sera of uremic patients and in the sera and brain of experimental uremic rabbits. Biochem Med 1976; 16: 1-8.
35. Glass RE, Goode AW, Houghton BJ, Rowell LW. Plasma arginine in cancer of the gastrointestinal tract: effect of surgical treatment. Gut 1986; 27: 844-848.
36. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-415.
37. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-692.
38. Radomski MW, Palmer RMJ, Read NG, Moncada S. Isolation and washing of human platelets with nitric oxide. Thromb Res 1988; 50: 537-546.
39. G-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 1990; 101: 10-12.
40. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
41. Hayde M, Vierhapper H, Lubec B, et al. Low-dose dietary L-arginine increases plasma interleukin 1-alpha but not interleukin 1-beta in patients with diabetes mellitus. Cytokine 1994; 6: 79-82.
42. Kharitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ. L-Arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 1995; 88: 135-139.
43. Samama CM, Diaby M, Fellahi J-L, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83: 56-65.